Qiqian Liu, Hui Liu, Pasquale Sacco, Nadia Djaker, Marc Lamy de la Chapelle, Eleonora Marsich, Xiaowu Li and Jolanda Spadavecchia
{"title":"撤回：ctl -阿霉素(DOX)-金复合纳米颗粒（DOX- augcs）：从合成到增强肝癌模型的治疗效果。","authors":"Qiqian Liu, Hui Liu, Pasquale Sacco, Nadia Djaker, Marc Lamy de la Chapelle, Eleonora Marsich, Xiaowu Li and Jolanda Spadavecchia","doi":"10.1039/D5NA90068A","DOIUrl":null,"url":null,"abstract":"<p >Retraction of “CTL–doxorubicin (DOX)–gold complex nanoparticles (DOX–AuGCs): from synthesis to enhancement of therapeutic effect on liver cancer model” by Qiqian Liu <em>et al.</em>, <em>Nanoscale Adv.</em>, 2020, <strong>2</strong>, 5231–5241, https://doi.org/10.1039/D0NA00758G.</p>","PeriodicalId":18806,"journal":{"name":"Nanoscale Advances","volume":" 20","pages":" 6659-6659"},"PeriodicalIF":4.6000,"publicationDate":"2025-09-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12478200/pdf/","citationCount":"0","resultStr":"{\"title\":\"Retraction: CTL–doxorubicin (DOX)–gold complex nanoparticles (DOX–AuGCs): from synthesis to enhancement of therapeutic effect on liver cancer model\",\"authors\":\"Qiqian Liu, Hui Liu, Pasquale Sacco, Nadia Djaker, Marc Lamy de la Chapelle, Eleonora Marsich, Xiaowu Li and Jolanda Spadavecchia\",\"doi\":\"10.1039/D5NA90068A\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p >Retraction of “CTL–doxorubicin (DOX)–gold complex nanoparticles (DOX–AuGCs): from synthesis to enhancement of therapeutic effect on liver cancer model” by Qiqian Liu <em>et al.</em>, <em>Nanoscale Adv.</em>, 2020, <strong>2</strong>, 5231–5241, https://doi.org/10.1039/D0NA00758G.</p>\",\"PeriodicalId\":18806,\"journal\":{\"name\":\"Nanoscale Advances\",\"volume\":\" 20\",\"pages\":\" 6659-6659\"},\"PeriodicalIF\":4.6000,\"publicationDate\":\"2025-09-29\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12478200/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Nanoscale Advances\",\"FirstCategoryId\":\"88\",\"ListUrlMain\":\"https://pubs.rsc.org/en/content/articlelanding/2025/na/d5na90068a\",\"RegionNum\":3,\"RegionCategory\":\"材料科学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"CHEMISTRY, MULTIDISCIPLINARY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nanoscale Advances","FirstCategoryId":"88","ListUrlMain":"https://pubs.rsc.org/en/content/articlelanding/2025/na/d5na90068a","RegionNum":3,"RegionCategory":"材料科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CHEMISTRY, MULTIDISCIPLINARY","Score":null,"Total":0}
Retraction: CTL–doxorubicin (DOX)–gold complex nanoparticles (DOX–AuGCs): from synthesis to enhancement of therapeutic effect on liver cancer model
Retraction of “CTL–doxorubicin (DOX)–gold complex nanoparticles (DOX–AuGCs): from synthesis to enhancement of therapeutic effect on liver cancer model” by Qiqian Liu et al., Nanoscale Adv., 2020, 2, 5231–5241, https://doi.org/10.1039/D0NA00758G.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
